-
721
-
722
BAM8-22 targets spinal MrgC receptors to modulate UPRmt activity in the mechanism of bone cancer pain
Published 2025-03-01Get full text
Article -
723
-
724
-
725
-
726
-
727
Decompensated MASH-Cirrhosis Model by Acute and Toxic Effects of Phenobarbital
Published 2024-10-01Get full text
Article -
728
-
729
Leveraging radiotherapy to improve immunotherapy outcomes: rationale, progress and research priorities
Published 2025-01-01Get full text
Article -
730
Non allergic gastrointestinal manifestations of hereditary alpha-tryptasemia
Published 2025-06-01Get full text
Article -
731
EXPERIMENTAL PARTICIPATION OF PHARMACOLOGICAL SUBSTANCES IN MECHANISMS OF LEAD ACETATE TOXICITY
Published 2023-02-01Get full text
Article -
732
-
733
IMMUNOREGULATORY IMBALANCE AND FUNCTIONAL STATE OF THE HEART IN THE PATIENTS WITH DIABETES MELLITUS TYPE 2
Published 2018-12-01“…The numbers of FoxP3+T egulatory lymphocytes, Treg/Th17 lymphocyte ratio, and mean fluorescence intensity of IL-17 for Th17 cells was lower in patients with diabetes mellitus and diastolic dysfunction compared to the patients with diabetes free of diastolic dysfunction. …”
Get full text
Article -
734
C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patients
Published 2025-06-01“…To this purpose we tested their capability to block C3 deposition and C5b-9 formation on microvascular endothelial cells (HMEC-1) exposed to serum from patients with aHUS. …”
Get full text
Article -
735
The Junction of Allergic Inflammation and Atherosclerosis: Pathways and Clinical Implications—A Review
Published 2025-06-01“…Epidemiological studies and review articles were included. <b>Results</b>: Emerging evidence suggests that allergic inflammation contributes to atherosclerosis through interconnected mechanisms such as eosinophil activation, reactive oxygen species production, mast cell degranulation, and endothelial dysfunction. …”
Get full text
Article -
736
Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherap...
Published 2025-06-01“…In vitro assays demonstrated that tumor-derived ILT3/APOE promoted recruitment and M2-like polarization of TAMs in LUAD and directly inhibited T cell proliferation and cytotoxicity. In vivo knockdown of gp49b enhanced anti-tumor immunity and suppressed tumor progression by counteracting TAM- and dysfunctional T cell-induced tumor microenvironment immunosuppression. …”
Get full text
Article -
737
The effect of a complex of melatonin, aluminum oxide and polymethylsiloxane on the cellular composition of the mice spleen kept in round-the-clock lighting conditions
Published 2021-10-01“…The administration of pure and modified melatonin (Complex M) to animals kept under round-the-clock lighting conditions has an equally pronounced normalizing effect on the cellular composition of B- (CD19) and T- (CD3) lymphocytes of the spleen, bringing the values of the studied parameters to the control values of the intact animals (p ≤ 0.001) Round-the-clock lighting affects the proliferative potential of splenocytes, reducing the number of cells in the G2/M phase, compared with animals treated with melatonin (p ≤ 0.050). …”
Get full text
Article -
738
Harnessing genomic and bioinformatic data to broaden understanding of leukaemia across continents
Published 2024-01-01“…PATJ maintains brain cell integrity, MINDY1 regulates gene expression, CDKN1B controls the cell cycle and ABCC8 regulates glucose levels. …”
Get full text
Article -
739
Ginsenoside C-K inhibits Aβ oligomer-induced Alzheimer's disease pathology progression by regulating microglia-neuron interactions
Published 2025-06-01“…Results: GCK pretreatment significantly ameliorated Aβ₁₋₄₂ oligomer-induced BV2 cell dysfunction (viability recovery rate >80 %, p < 0.01), suppressed pro-inflammatory cytokine secretion (TNF-α reduced by 62.3 %, IL-1β by 57.8 %), and inhibited NF-κB pathway activation (p-IκBα/p-p65 expression downregulated >50 %). …”
Get full text
Article -
740